Yayın: 1‐N‐Substituted Thiocarbamoyl‐3‐phenyl‐5‐thienyl‐2‐pyrazolines: Synthesis and Evaluation as MAO Inhibitors
| dc.contributor.author | Erol, Kevser | |
| dc.contributor.author | Akgül Yeşilada | |
| dc.contributor.author | Gülberk Uçar | |
| dc.contributor.author | Kevser Erol | |
| dc.contributor.author | A. Altan Bilgin | |
| dc.contributor.orcid | 0000-0002-3541-2676 | |
| dc.contributor.orcid | 0000-0002-8594-2915 | |
| dc.contributor.orcid | 0000-0002-8647-1545 | |
| dc.contributor.orcid | 0000-0002-8808-6616 | |
| dc.contributor.orcid | 0000-0003-1732-475X | |
| dc.date.accessioned | 2025-11-13T09:15:47Z | |
| dc.date.issued | 2003-08-01 | |
| dc.identifier.doi | https://doi.org/10.1002/ardp.200300732 | |
| dc.identifier.endpage | 371 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issue | 8 | |
| dc.identifier.openalex | W2052001291 | |
| dc.identifier.startpage | 362 | |
| dc.identifier.uri | https://hdl.handle.net/11421/938 | |
| dc.identifier.uri | https://doi.org/10.1002/ardp.200300732 | |
| dc.identifier.volume | 336 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Archiv der Pharmazie | |
| dc.rights | restrictedAccess | |
| dc.subject | Chemistry | |
| dc.subject | Monoamine oxidase | |
| dc.subject | In vivo | |
| dc.subject | Stereochemistry | |
| dc.subject | Pyrazoline | |
| dc.subject | Monoamine oxidase B | |
| dc.subject | In vitro | |
| dc.subject | Chemical synthesis | |
| dc.subject | Selectivity | |
| dc.subject | Enzyme | |
| dc.subject | Enzyme inhibitor | |
| dc.subject | Antidepressant | |
| dc.subject | Biochemistry | |
| dc.subject | Medicinal chemistry | |
| dc.subject | Biology | |
| dc.subject.sdg | 3 | |
| dc.title | 1‐N‐Substituted Thiocarbamoyl‐3‐phenyl‐5‐thienyl‐2‐pyrazolines: Synthesis and Evaluation as MAO Inhibitors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5047198917 |
